• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘的静脉注射茶碱治疗:临床最新进展

Intravenous theophylline therapy in asthma: a clinical update.

作者信息

Rothstein R J

出版信息

Ann Emerg Med. 1980 Jun;9(6):327-30. doi: 10.1016/s0196-0644(80)80070-9.

DOI:10.1016/s0196-0644(80)80070-9
PMID:7386959
Abstract

Theophylline preparations have long been the mainstay in the management of asthma. Recently clinical and laboratory investigations have provided us with some useful information regarding the appropriate dosage and elimination of the drug. If morbidity is to be avoided, knowledge of the basic pharmacokinetics of theophylline, as well as recognition of the parameters which have clinically significant influences on those kinetics, is essential to the emergency physician who has occasion to treat asthmatics. Theophylline levels should be utilized whenever available, but clinical acumen must suffice in their absence. Subtle signs of toxicity must be recognized before more serious complications ensue. Armed with more recent knowledge, the emergency physician should be able to provide optimal therapy for the asthmatic.

摘要

茶碱制剂长期以来一直是哮喘治疗的主要药物。最近,临床和实验室研究为我们提供了一些关于该药物合适剂量和消除的有用信息。为避免发病,了解茶碱的基本药代动力学,以及认识对这些动力学有临床显著影响的参数,对于有机会治疗哮喘患者的急诊医生来说至关重要。只要有条件,就应检测茶碱水平,但在无法检测时,临床敏锐度必须足够。在更严重的并发症出现之前,必须识别出毒性的细微迹象。有了最新的知识,急诊医生应该能够为哮喘患者提供最佳治疗。

相似文献

1
Intravenous theophylline therapy in asthma: a clinical update.哮喘的静脉注射茶碱治疗:临床最新进展
Ann Emerg Med. 1980 Jun;9(6):327-30. doi: 10.1016/s0196-0644(80)80070-9.
2
Incidence of apparent Michaelis-Menten kinetic behavior of theophylline and its parameters (Vmax and Km) among asthmatic children and adults.哮喘儿童和成人中茶碱的表观米氏动力学行为及其参数(Vmax和Km)的发生率。
Ther Drug Monit. 1987;9(1):11-20. doi: 10.1097/00007691-198703000-00003.
3
Update on the pharmacodynamics and pharmacokinetics of theophylline.茶碱的药效学和药代动力学最新进展。
Chest. 1985 Aug;88(2 Suppl):103S-111S. doi: 10.1378/chest.88.2_supplement.103s.
4
[Intravenous theophylline in the treatment of asthma attacks].静脉注射茶碱治疗哮喘发作
Allerg Immunol (Paris). 1987 Feb;19(2):61-4.
5
Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (theolair and Theolair retard) in normals and asthmatics. Part I: pharmacokinetics.短效和长效茶碱药物(Theolair和Theolair缓释片)在正常人和哮喘患者中的药代动力学和药效学。第一部分:药代动力学。
Int J Clin Pharmacol Ther Toxicol. 1983 Jun;21(6):287-91.
6
[Pharmacokinetics of a new slow-release theophylline preparation in asthmatic children].[一种新型缓释茶碱制剂在哮喘儿童中的药代动力学]
An Esp Pediatr. 1985 Apr 15;22(5):383-92.
7
Theophylline therapy. Titrating dosage requirements.茶碱治疗。滴定剂量需求。
Postgrad Med. 1984 Jun;75(8):247-56. doi: 10.1080/00325481.1984.11698651.
8
Lack of effect of repirinast on the pharmacokinetics of theophylline in asthmatic patients.瑞吡司特对哮喘患者茶碱药代动力学无影响。
Eur J Clin Pharmacol. 1989;37(3):301-3. doi: 10.1007/BF00679789.
9
Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule.用于慢性哮喘的茶碱:治疗原理、产品选择及给药方案
Pediatr Pharmacol (New York). 1983;3(3-4):273-85.
10
Pharmacokinetics of theophylline in young children with asthma: comparison of rectal enema and suppositories.哮喘患儿中茶碱的药代动力学:直肠灌肠剂与栓剂的比较。
Eur J Clin Pharmacol. 1979 Sep;16(2):133-9. doi: 10.1007/BF00563120.

引用本文的文献

1
Purinergic Signaling in Mast Cell Degranulation and Asthma.嘌呤能信号传导在肥大细胞脱颗粒和哮喘中的作用
Front Pharmacol. 2017 Dec 22;8:947. doi: 10.3389/fphar.2017.00947. eCollection 2017.
2
Has emergency medicine research benefited patients? An ethical question.
Sci Eng Ethics. 2007 Sep;13(3):289-95. doi: 10.1007/s11948-007-9025-6.